Search

Your search keyword '"Marti-Fabregas, Joan"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Marti-Fabregas, Joan" Remove constraint Author: "Marti-Fabregas, Joan"
118 results on '"Marti-Fabregas, Joan"'

Search Results

1. Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

2. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

5. Frequency, Predictors, Etiology, and Outcomes for Deep Intracerebral Hemorrhage without Hypertension

6. The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm

9. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

10. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

11. Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage: A Population-Based Study.

13. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

14. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data

16. Recommendations for Clinical Trials in ICH: The Second Hemorrhagic Stroke Academia Industry Roundtable

17. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis

19. Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

23. Table_2_A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype.XLSX

24. Additional file 1 of Altered methylation pattern in EXOC4 is associated with stroke outcome: an epigenome-wide association study

25. Supplementary Material DNA methylation is associated with ischemic stroke risk: An Epigenome-Wide association study

26. Supplemental Material Biological age acceleration is lower in women with Ischemic Stroke compared to men

27. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

28. Biological Age Acceleration Is Lower in Women with Ischemic Stroke Compared to Men

29. DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study

30. Stroke genetics informs drug discovery and risk prediction across ancestries

33. Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment

34. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

35. Uric Acid Treatment After Stroke Prevents Long-Term Middle Cerebral Artery Remodelling and Attenuates Brain Damage in Spontaneously Hypertensive Rats

36. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

37. Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic stroke

38. A Genome-Wide Meta-Analysis

39. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018

40. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis

41. A Genome-Wide Meta-Analysis

43. Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review

44. Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke

47. Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow

48. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial

49. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

Catalog

Books, media, physical & digital resources